Table V.
The associations between the expression levels of miR-650 (2−ΔCt) and CA211 in plasma and clinicopathological factors of patients with gastric cancer.
| Parameter | na | miR-650a, average fold-change ± SD | P-valuea | nb | CA211b | P-valueb |
|---|---|---|---|---|---|---|
| Age, median years | 0.1489 | 0.0537 | ||||
| <60 | 30 | 23.23±48.69 | 11 | 2.795±1.25 | ||
| ≥60 | 60 | 6.83±10.09 | 29 | 3.89±40.95 | ||
| Sex | 0.7122 | 0.9856 | ||||
| Male | 68 | 15.04±31.14 | 31 | 4.63±44.67 | ||
| Female | 22 | 26.15±62.19 | 9 | 3.09±57.66 | ||
| TNM stage | 0.4769 | 0.1064 | ||||
| I | 22 | 15.72±25.86 | 6 | 0.67±1.86 | ||
| II | 8 | 13.21±26.40 | 5 | 3.09±0.78 | ||
| III | 13 | 4.00±6.32 | 9 | 4.48±22.67 | ||
| IV | 47 | 14.94±33.96 | 20 | 3.89±58.55 | ||
| Histological type | 0.6947 | 0.7942 | ||||
| A | 63 | 3.42±47.52 | 28 | 3.415±45.56 | ||
| Other | 27 | 4.01±10.43 | 12 | 3.26±1.33 |
miR, microRNA; CA211, carbohydrate antigen 211; SD, standard deviation; TNM, Tumor-Node-Metastasis; A, adenocarcinoma. ‘Other’ refers to mucinous carcinoma, Signet-ring cell carcinoma and adenocarcinoma with Signet-ring cell carcinoma.
a
The 90 patients with GC included in the present study
b
The 40 patients with GC who participated in CA211 test.